Floatz logo

Vinblastine

Renal Pelvis/Ureter Urothelial Carcinoma

University of Southern CaliforniaSmall moleculePhase 3Dormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Renal Pelvis/Ureter Urothelial Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
Cardiff University
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
Nagoya University
Phase 3BBB
METHOTREXATE
University of Southern California
Phase 3BBB
Adriamycin
University of Southern California
Phase 3BBB
Nivestim
Tulane University Health Sciences Center
Phase 2BBB

View all 49 →

Same molecule, other indications

Vinblastine is also rated in:

carcinoma of urethraDormant
BBB
Indicative · Phase 3
73 / 100
View asset →
Hodgkins lymphomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →
lymphomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →